Company raises $55M to advance therapies for celiac, other autoimmune disorders
Biotech company Mozart Therapeutics has raised $55 million in Series A funding. Mozart is targeting autoimmune and inflammatory diseases through a network of what are called CD8 regulatory T cells. The work is built on the research of T cell biology expert Mark M. Davis. Mozart said the Series A will help the company to progress its treatment to the clinic while advancing oth er programs as well. "Mozart is doing something truly unique to change the treatment paradigm for patients with autoimmune… (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - October 29, 2021 Category: Pharmaceuticals Authors: Rick Morgan Source Type: news

Company raises $55M to advance therapies for celiac, other autoimmune disorders
Biotech company Mozart Therapeutics has raised $55 million in Series A funding. Mozart is targeting autoimmune and inflammatory diseases through a network of what are called CD8 regulatory T cells. The work is built on the research of T cell biology expert Mark M. Davis. Mozart said the Series A will help the company to progress its treatment to the clinic while advancing oth er programs as well. "Mozart is doing something truly unique to change the treatment paradigm for patients with autoimmune… (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - October 29, 2021 Category: Biotechnology Authors: Rick Morgan Source Type: news

New research identifies who should be offered testing for coeliac disease
Targeted testing of individuals with a range of signs and symptoms could improve diagnosis of coeliac disease, a new National Institute for Health Research (NIHR) funded study led by the University of Bristol and published in PLOS ONE has found. Signs and symptoms include family history of coeliac disease, dermatitis herpetiformis, anaemia, type 1 diabetes, osteoporosis and chronic liver disease. (Source: University of Bristol news)
Source: University of Bristol news - October 25, 2021 Category: Universities & Medical Training Tags: Health, Research; Faculty of Health Sciences, Faculty of Health Sciences, Bristol Medical School, Institutes, Bristol Population Health Science Institute, Faculty of Health Sciences, Population Health Sciences; Press Release Source Type: news

What Causes Irritability?
Discussion Child abuse or non-accidental trauma is a clinical diagnosis. It is the constellation of history, physical examination, radiographic evaluation, laboratory testing and investigation that determines if child abuse has occurred. Irritability caused by fractures or other trauma can be a presenting symptom of abuse. Fractures can be a presentation but they are also common problems not associated with abuse. Femoral shaft fractures are estimated to account for only 1.6% of all fractures in children, therefore they are potentially more suspicious for child abuse. A review of femur fractures can be found here. A review...
Source: PediatricEducation.org - October 18, 2021 Category: Pediatrics Authors: Pediatric Education Tags: Uncategorized Source Type: news

HLA Genotype as a Risk Factor for Celiac Disease Among Relatives HLA Genotype as a Risk Factor for Celiac Disease Among Relatives
The presence of a high-risk genotype is the most important predictor of screening positivity, according to this study of various patient- and relative-related factors on the risk of celiac disease.Alimentary Pharmacology & Therapeutics (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - October 6, 2021 Category: Consumer Health News Tags: Gastroenterology Journal Article Source Type: news

Coeliac patients in Switzerland have lower WTP for a & quot;cure & quot; if they find the GF diet healthy
(Source: PharmacoEconomics and Outcomes News)
Source: PharmacoEconomics and Outcomes News - October 1, 2021 Category: Drugs & Pharmacology Source Type: news

Gluten-Free Diet May Reduce Cancer Risk in Celiac Disease Gluten-Free Diet May Reduce Cancer Risk in Celiac Disease
The increased risk for cancer among people with celiac disease decreased over time. It may be related to the beneficial effect of the gluten-free diet in the long term.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - September 14, 2021 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

Specially designed monoclonal antibodies may prevent celiac disease, study finds
Antibody therapy may help prevent the development of celiac disease, the digestive disorder that limits the body's ability to process foods containing wheat, barley and rye, a study published by Science Immunology. (Source: Health News - UPI.com)
Source: Health News - UPI.com - August 20, 2021 Category: Consumer Health News Source Type: news

Raleigh firm's drug could help fight rare Covid-related syndrome in children
As Covid-19 cases rise among children, a celiac treatment developed in Raleigh may hold answers to treating a rare, potentially deadly syndrome linked to the disease. (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - August 18, 2021 Category: Biotechnology Authors: Lauren Ohnesorge Source Type: news

Try These 3 Tips to Lose Those Pandemic Pounds
WEDNESDAY, Aug. 4, 2021 – If you ' re like many people, your waistline has expanded during the pandemic. " The world shut down, " said Heather Tressler, a registered dietitian at the Penn State Celiac Clinic at Penn State Health ' s Milton S. Hershey... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - August 4, 2021 Category: General Medicine Source Type: news

Coeliac disease diet: The 16 foods YOU should avoid to ease symptoms
COELIAC disease affects millions around the world, but an estimated half a million Britons do not realise they suffer from the condition. But what foods should be avoided? (Source: Daily Express - Health)
Source: Daily Express - Health - August 2, 2021 Category: Consumer Health News Source Type: news

Johnson & Johnson Innovation Announces Extension Of Innovation Partnering Office at Monash University In Collaboration With Victorian State Government To Accelerate The Life-Sciences Hub
MELBOURNE, Australia, July 15, 2021 -- Johnson & Johnson Innovation announced today the extension of the Johnson & Johnson Innovation Partnering Office at Monash University's Clayton Campus in Melbourne (JJIPO@Monash) in collaboration with the Victorian State Government.This joint initiative between Johnson & Johnson Innovation, the Victorian Government and Monash University will be extended for approximately two years through June 30, 2023. The agreement will allow JJIPO@Monash to continue connecting with the Victorian innovation ecosystem, nurturing and accelerating innovative research, new product developmen...
Source: Johnson and Johnson - July 15, 2021 Category: Pharmaceuticals Tags: Our Company Source Type: news

Can Gut Changes Predict Celiac Disease?
(Source: eMedicineHealth.com)
Source: eMedicineHealth.com - July 13, 2021 Category: General Medicine Source Type: news

Can Gut Changes Predict Celiac Disease? Can Gut Changes Predict Celiac Disease?
Distinct changes in the gut microbiome precede the development of celiac disease in at-risk infants; the finding could provide novel therapeutic and preventive targets.Medscape Medical News (Source: Medscape Gastroenterology Headlines)
Source: Medscape Gastroenterology Headlines - July 13, 2021 Category: Gastroenterology Tags: Gastroenterology News Source Type: news

Celiac Disease: Novel Oral Inhibitor May Block Intestinal Damage Celiac Disease: Novel Oral Inhibitor May Block Intestinal Damage
A randomized, phase 2 trial explored the safety and efficacy of ZED1227, a transglutaminase inhibitor, after 6 weeks at three doses.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - July 2, 2021 Category: Consumer Health News Tags: Gastroenterology News Source Type: news